GI Oncology
Conference Coverage
Targeted Colorectal Cancer Combo Improves QoL
The results of a new trial may point the way to other dual therapies involving kinase inhibitors, says expert.
Conference Coverage
Immunotherapy Combo Wins Big on PFS in First-Line Mets CRC
The findings of a new study indicate that nivolumab plus ipilimumab should really be “a new standard,” a medical oncologist says.
From the Journals
GLP-1 RAs Associated With Reduced Colorectal Cancer Risk in Patients With Type 2 Diabetes
More profound effects were seen in patients with overweight or obesity, “suggesting a potential protective effect against CRC partially mediated...
News
Pancreatic cystic neoplasms rarely turn cancerous, study shows
Study is the first to report the proportion of pancreatic cancers that develop from cystic neoplasms.
News
Meta-analysis of postcancer use of immunosuppressive therapies shows no increase in cancer recurrence risk
Findings could guide clinical decision making for starting immunosuppression in patients with a history of malignancy.
News
Microsimulation model identifies 4-year window for pancreatic cancer screening
Study highlights a window of opportunity for pancreatic cancer screening suggesting current surveillance guidelines be re-evaluated.
From the Journals
High-risk colon polyps detected at screening colonoscopy linked to liver cancer death
“Our findings imply that risk stratification at colonoscopy might be helping to identify patients at need for liver cancer surveillance.”
News
Hemostatic powder superior in controlling tumor bleeding
Standard endoscopic interventions resulted in lower rates of immediate hemostasis and more rebleeds.
From the Journals
AI tool predicts certain GI cancers years in advance
Because K-ECAN does not rely heavily on GERD symptoms to assess risk, it has the “potential to guide providers to increase appropriate uptake of...
From the Journals
‘Game changer’ data for vitamin D in digestive tract cancers
In the p53-immunoreactive subgroup, daily vitamin D supplementation reduced the risk of relapse or death by 73%.
Latest News
Should race and ethnicity be used in CRC recurrence risk algorithms?
Removing race from clinical risk predictions could lead to higher racial bias in model accuracy and less accurate estimation of risk in some...